Bart C. De Jonghe, PhD, on Inflammation, Obesity and Cancer

Video

Bart C. De Jonghe, PhD, assistant professor, School of Nursing, University of Pennsylvania, discusses inflammation, obesity and cancer.

Bart C. De Jonghe, PhD, assistant professor, School of Nursing, University of Pennsylvania, discusses inflammation, obesity and cancer.

De Jonghe says when a cancer patient is obese and undergoing treatment, it can create a “perfect inflammatory storm.” Current research is looking to see which pathways are affected by obesity and cancer and if any of the inflammatory responses overlap.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Related Content
sarcoma

Oncology Nurses, APPs Play a ‘Unique Role’ in Sarcoma Treatment

Darlene Dobkowski, MA
October 7th 2024
Article

An expert explained the role oncology nurses and advanced practice providers play in caring for patients with sarcoma during treatment.

Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

Lindsay Fischer
September 1st 2022
Podcast

In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.

lung cancer

Should You Wait for NGS Results Before Initiating NSCLC Treatment?

Lindsay Fischer
November 17th 2023
Article

Beth Sandy, MSN, CRNP, and Tajuana Bradley, MSN, APRN-BC, discuss the importance of molecular testing in non–small cell lung cancer.

bell © New Africa

Is It Time to Rethink the Bell Ringing Ceremony in Cancer Care?

Lindsay Fischer
September 27th 2023
Article

Lindsey Zinck, PhD, RN, OCN, NEA-BC, and Melania Zisa, RN, BSN, OCN, discuss why it may be time to make the bell ringing ceremony a more inclusive celebration in cancer care.

blood cells

Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML

Jordyn Sava
September 19th 2023
Article

Quizartinib plus standard intensive induction and consolidation therapy was associated with longer survival rates in patients with FLT3-ITD–positive acute myeloid leukemia.

Symptom Assessments, Guidelines Inform Nurses Whether They Are ‘Moving in the Right Direction’ in MPN Treatment

Symptom Assessments, Guidelines Inform Nurses Whether They Are ‘Moving in the Right Direction’ in MPN Treatment

Darlene Dobkowski, MA
August 22nd 2023
Article

Tetyana Furmanets, CRNP, MSN, discusses the tools she uses to help patients navigate myeloproliferative neoplasm symptom management.